Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.445 USD | +1.02% | -8.57% | -26.67% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 12.13M | Capitalization | 23.49M |
---|---|---|---|---|---|
Net income 2024 * | -38M | Net income 2025 * | -19M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
-0.61
x | P/E ratio 2025 * |
-1.39
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.48% |
Latest transcript on Iterum Therapeutics plc
1 day | -2.05% | ||
1 week | -12.80% | ||
Current month | -7.14% | ||
1 month | -12.27% | ||
3 months | -24.34% | ||
6 months | +113.43% | ||
Current year | -27.41% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Dunne
FOU | Founder | 64 | 15-10-31 |
Corey N. Fishman
FOU | Founder | 59 | 15-06-23 |
Director of Finance/CFO | 54 | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ron Hunt
CHM | Chairman | 59 | 15-10-31 |
Beth Hecht
BRD | Director/Board Member | 60 | 21-03-11 |
Corey N. Fishman
FOU | Founder | 59 | 15-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.445 | +1.02% | 31 422 |
24-04-18 | 1.43 | -2.05% | 56,746 |
24-04-17 | 1.46 | +0.69% | 76,340 |
24-04-16 | 1.45 | -7.64% | 169,564 |
24-04-15 | 1.57 | -0.63% | 98,833 |
Delayed Quote Nasdaq, April 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.41% | 23.49M | |
-1.82% | 41.35B | |
+42.44% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- ITRM Stock